Chemotherapy in China: Obtaining a Written Follow-Up Plan

First, separate the two questions a follow-up plan must answer

A chemotherapy follow-up plan can serve two different purposes, and mixing them is the main reason patients leave a consultation without the document they need. The first is a review of a new regimen: the team is deciding whether a proposed approach is appropriate, what alternatives exist, and what information is still missing. The second is continuation of ongoing treatment: cycles are underway, and the question is how the next cycle, monitoring and review points are coordinated.

These lead to different written content. A new-regimen review should record what the team assessed, what it still needs, and what it cannot yet conclude. An ongoing-treatment plan should record the cycle structure the prescriber has set, which monitoring is expected, and who reviews the results. Chemotherapy uses drugs to kill or slow the growth of cancer cells, and treatment schedules differ according to the prescribed regimen, so the written plan has to reflect the specific regimen rather than a general description.

Before you ask for anything in writing, confirm which situation you are in. If you are not sure, say so plainly: "I need to know whether this review is about starting a new regimen or continuing my current one, because the follow-up plan I need is different." That single question changes what the clinician should document.

It also changes what you should not expect. A review does not establish that a particular regimen is available to you, that a hospital will accept your case, or that you are fit to travel. Those are separate decisions made by the treating hospital and its clinicians. The written plan is a record of clinical reasoning and next steps, not a booking confirmation.

What the written plan should name about review items

A useful follow-up plan is specific about what will be reviewed and why. Ask the clinician to write down the purpose of each review point in one line, not just a test name. "Blood count before cycle two to check recovery" tells you more than "bloods". The reason matters because it lets your local clinician understand what the overseas team is watching for.

Ask which results the plan depends on and where they should come from. If monitoring is expected between cycles, the plan should state who orders it, where it can be done, and how the results reach the treating team. If some monitoring can be done locally in your home country and some must be done at the treating hospital, that division should appear in writing. Do not assume a division of labour; ask for it to be recorded.

Ask what would change the plan. A written follow-up plan that only lists scheduled reviews is incomplete, because clinical teams adjust based on how a patient responds. You do not need a decision tree, but you do need to know which findings would prompt an earlier review, a change of approach, or a discussion with you. Ask: "What would make you bring the next review forward, and who would contact me if that happened?"

Finally, ask what the plan does not cover. If the document addresses cycle coordination but not supportive care, symptom management or a future reassessment, that gap should be visible. A plan with clear boundaries is easier to act on than one that appears comprehensive but leaves the important parts unstated.

Records: what to hand over and what to ask for back

The records side of a chemotherapy follow-up plan runs in two directions. You provide your existing history; the treating team provides a record of what it has assessed and decided. Both should be documented, and you should know what is still missing on each side.

On your side, the relevant material usually includes the diagnosis and pathology information, imaging and staging documents, the regimens already used with cycle dates, the results of recent monitoring, current medicines, allergies and any other active conditions. Bring these in a form the team can read and keep. If a document is unavailable, say so rather than leaving the team to assume it does not exist. A missing record is a question to resolve, not a reason to delay urgent local care.

On the team's side, ask what will be written into your file and what you will receive. At minimum, ask for a copy of the follow-up plan itself, a summary of the assessment, and the contact details for the person or department responsible for the next step. If the plan refers to results that were generated during your visit, ask how and when you can obtain copies.

Ask explicitly how records will be shared if part of your care continues elsewhere. If your home clinician needs the plan, the imaging or the monitoring results, ask what format and what route the hospital uses. Do not assume that a portal, an email or a printed folder is available; ask which one applies to your case and confirm it in writing.

Contacts and responsibility: who owns each next step

A frequent weak point in an overseas follow-up plan is not a missing test; it is an unnamed owner. A plan that says "review in due course" without saying who reviews, who contacts whom, and through which channel is difficult to act on from another country.

Ask the team to write down, for each next step, the responsible role and the contact route. That means a named department or clinical role, the channel through which you should raise questions, and what response you should expect. You do not need a personal mobile number, and you should not ask for one. You need to know whether questions go to the treating clinician, a coordinator, a nursing line or an outpatient department, and what each of those can and cannot answer.

Ask what happens outside working hours and at weekends. If a concern arises between cycles, the plan should say where you should go first. That may be your local emergency service, your home clinician, or a specified hospital contact. Ask the team to state this clearly rather than leaving you to guess.

Ask who is responsible for the handover if your care moves between departments or between the treating hospital and your home clinician. A written plan should identify who sends the records, who receives them, and who confirms that the handover has happened. If no one is named, the plan is incomplete.

One practical administrative example: if you are coordinating appointments through a non-clinical service, the clinical plan and the appointment logistics are separate documents. The clinical plan states what should happen and who decides; the logistics record states what has been requested and what has been confirmed. Keep them apart so that a provisional appointment is never mistaken for a clinical decision.

Related treatment reference

Cycle coordination and monitoring: the questions that change the plan

If your review concerns ongoing treatment, cycle coordination is the core of the written plan. Ask the prescriber to document the regimen, the intended cycle structure and the review points that sit around it. Because schedules differ according to the prescribed regimen, a general statement about chemotherapy cycles is not enough; the plan should reflect your regimen as prescribed.

Ask how monitoring is timed relative to each cycle. The plan should state which assessments are expected before a cycle proceeds, which are expected during or after it, and who acts on the results. If a result falls outside an expected range, the plan should say who decides whether the cycle continues, pauses or changes, and how you would be informed.

Ask how the plan handles travel and time zones. If part of your monitoring happens at home and part at the treating hospital, the plan should state how results are transmitted and how quickly a decision can be made. Do not assume that remote review is possible; ask whether it is, and ask for the answer in writing.

Ask what the plan assumes about your availability. If a review point requires you to be physically present, that should be stated. If it can be done remotely, that should be stated too. The purpose is not to create a fixed itinerary but to make the dependencies visible so that you and your home clinician can plan around them.

Finally, ask how the plan will be updated. A follow-up plan written at one point in time will need revision as results come in. Ask who updates it, how you receive the updated version, and how your home clinician is kept informed. A plan that cannot be updated is a snapshot, not a follow-up plan.

Before you leave: confirm the document, then take the next step

Before you leave the clinical area, confirm four things in the written plan: the purpose of the review, the records and results it depends on, the contact route for questions, and the named owner of each next step. If any of these is missing, ask for it to be added rather than relying on memory or a verbal summary.

Ask for the plan in a form you can keep and share. Confirm whether it is in English, whether a translation is available, and whether your home clinician can receive a copy directly. If the answer is that a document will follow later, ask when and through which channel, and record that answer.

Keep the clinical plan separate from any appointment or travel arrangements. A confirmed appointment is not a clinical decision, and a clinical plan is not a guarantee that a hospital will accept your case or that a particular treatment will be available to you. The treating hospital and its clinicians decide suitability, and no outcome is guaranteed.

If you are considering care in China and want help identifying the right next step, you can start with a free initial enquiry. Share a brief summary of the diagnosis, the treatment already received and your main question; the team will check what information is available, point out what is missing, and suggest a relevant route. You do not need to send a complete medical archive or purchase a proxy consultation to begin. A proxy consultation is optional and is not a prerequisite for an appointment.